Global Point-of-Care Molecular Diagnostics Market

$2,750.00

产品代码: GH03756R 行业: 地区:

据Gen咨询公司称, the global point-of-care molecular diagnostics market is set to achieve an incremental growth of USD 12.3 十亿, 复合年增长率几乎达到 14.7% 在预测期内 2022-2028.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global point-of-care molecular diagnostics market. 它追踪市场的历史和预测市场增长. 该报告根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the point-of-care molecular diagnostics industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对应用的详细分析, 技术, 应用, 和地区. The global market for point-of-care molecular diagnostics can be segmented by application: 传染性疾病, 癌症, hematology, prenatal testing, endocrinology, 其他的. The infectious diseases segment is estimated to account for the largest share of the global point-of-care molecular diagnostics market. Point-of-care molecular diagnostics market is further segmented by technology: PCR-based, microarray-based, hybridization-based, genetic sequencing-based. The PCR-based segment held the largest revenue share in 2021. 根据应用, the point-of-care molecular diagnostics market is segmented into: decentralized lab, 医院, 家庭, assisted living facility, 其他的. 全球范围, the decentralized lab segment made up the largest share of the point-of-care molecular diagnostics market. 根据地区, the point-of-care molecular diagnostics market also can be divided into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. North America was the largest contributor to the global point-of-care molecular diagnostics market in 2021.

市场细分
按申请: 传染性疾病, 癌症, hematology, prenatal testing, endocrinology, 其他的
按技术: PCR-based, microarray-based, hybridization-based, genetic sequencing-based
按申请: decentralized lab, 医院, 家庭, assisted living facility, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The market research report covers the analysis of key stake holders of the global point-of-care molecular diagnostics market. Some of the leading players profiled in the report include Abbott Laboratories, Bio-Rad 实验室, 公司, Quest Diagnostics, 公司, 罗氏控股公司, 西门子公司, 丹纳赫公司, BioMerieux SA, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
To analyze and forecast the market size of the global point-of-care molecular diagnostics market.
To classify and forecast the global point-of-care molecular diagnostics market based on application, 技术, 应用, 地区.
To identify drivers and challenges for the global point-of-care molecular diagnostics market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global point-of-care molecular diagnostics market.
To identify and analyze the profile of leading players operating in the global point-of-care molecular diagnostics market.

为什么选择这份报告
Gain a reliable outlook of the global point-of-care molecular diagnostics market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.

Global Point-of-Care Molecular Diagnostics Market

对这份报告感兴趣? 立即获取免费样品!
Global Point-of-Care Molecular Diagnostics Market - 报告范围
报告属性

细节

基准年

2021

预测年份

2022-2028

复合年增长率 (2022-2028)

14.73%

页数

86

行业参与者

雅培实验室, Bio-Rad 实验室公司, 奎斯特诊断公司, 罗氏控股公司, 西门子公司, 丹纳赫公司, BioMerieux SA

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Point-of-Care Molecular Diagnostics Market

请填写我们的表格,我们会尽快回复您.